CRDL Stock Price | Cardiol Therapeutics Inc Class A P/E, Revenue, EPS, & Forecasts

Cardiol Therapeutics Inc Class A • CRDL

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Cardiol Therapeutics Inc Class A

Ticker

CRDL

Trading on

NASDAQ

ISIN

CA14161Y2006

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

CEO

David G. Elsley MBA

Headquarters

2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5

Employees

Website

cardiolrx.com

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Metrics

BasicAdvanced

Market cap

$93.8M

P/E ratio

EPS

-$0.38

Dividend Yield

0.00%

Beta

0.57

Forward P/E ratio

EBIDTA

$-38.2M

Ex dividend date

Price & volume

Market cap

$93.8M

Average daily volume

0.3M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

1,069.35

Price to book

12.84

Earnings

EPS

-$0.38

EPS estimate (current quarter)

-$0.11

EPS estimate (next quarter)

-$0.11

EBITDA

$-38.2M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

0.57

52-week High

$3.12

52-week Low

$1.02

50-day moving average

$1.29

200-day moving average

$1.83

Short ratio

5.74

Short %

1.88%

Management effectiveness

ROE (TTM)

159.53%

ROA (TTM)

79.07%

Profit margin

0.00%

Gross profit margin

$0.1M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

81.6M

Float

77.7M

Insiders %

4.00%

Institutions %

12.20%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 5 analysts.

Average price target

$8.71

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.09

Q4 • 23Beat

-$0.12

Q1 • 24Beat

-$0.10

-$0.13

23.08%

Q2 • 24Beat

-$0.18

-$0.08

125.00%

Q3 • 24Beat

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-6.6M

∞%

Q2 • 24

$0M

$-12.7M

∞%

Q3 • 24

NaN%

93.12%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$26.3M

$11M

41.62%

Q2 • 24

$17.5M

$7.1M

40.46%

Q3 • 24

33.42%

35.28%

2.79%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-4.8M

$-0M

$0.1M

$-4.8M

Q2 • 24

$-7.8M

$-0M

$-7.8M

Q3 • 24

62.68%

107.13%

105.91%

62.71%

QoQ growth

QuarterlyAnnual

Sentiment analysis

-1.5

Greed

+1.5

0.75

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Cardiol Therapeutics Inc Class A share?

Cardiol Therapeutics Inc Class A shares are currently traded for undefined per share.

How many shares does Cardiol Therapeutics Inc Class A have?

Cardiol Therapeutics Inc Class A currently has 81.6M shares.

Does Cardiol Therapeutics Inc Class A pay dividends?

No, Cardiol Therapeutics Inc Class A doesn't pay dividends.

What is Cardiol Therapeutics Inc Class A 52 week high?

Cardiol Therapeutics Inc Class A 52 week high is $3.12.

What is Cardiol Therapeutics Inc Class A 52 week low?

Cardiol Therapeutics Inc Class A 52 week low is $1.02.

What is the 200-day moving average of Cardiol Therapeutics Inc Class A?

Cardiol Therapeutics Inc Class A 200-day moving average is $1.83.

Who is Cardiol Therapeutics Inc Class A CEO?

The CEO of Cardiol Therapeutics Inc Class A is David G. Elsley MBA.

How many employees Cardiol Therapeutics Inc Class A has?

Cardiol Therapeutics Inc Class A has 0 employees.

What is the market cap of Cardiol Therapeutics Inc Class A?

The market cap of Cardiol Therapeutics Inc Class A is $93.8M.

What is the P/E of Cardiol Therapeutics Inc Class A?

The current P/E of Cardiol Therapeutics Inc Class A is null.

What is the EPS of Cardiol Therapeutics Inc Class A?

The EPS of Cardiol Therapeutics Inc Class A is -$0.38.

What is the PEG Ratio of Cardiol Therapeutics Inc Class A?

The PEG Ratio of Cardiol Therapeutics Inc Class A is null.

What do analysts say about Cardiol Therapeutics Inc Class A?

According to the analysts Cardiol Therapeutics Inc Class A is considered a buy.